Clinical Trial Update: Extract of Ginkgo Biloba (EGB 761) and Vascular Function [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study evaluating EGb 761 Ginkgo biloba extract for vascular function in intermittent claudication and peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• EGb 761 (Ginkgo biloba extract) (Ginkgo biloba extract (EGb 761))

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Intermittent Claudication, Peripheral Vascular Disease | Phase 1, Phase 2 | Status: COMPLETED